Covid-19 Booster Shot for Immunocompromised Awaits FDA’s Approval

Amid the surge in cases due to the more contagious Delta variant, people with compromised immune systems in the US – about 2.7 percent of the country’s adult population-  can expect the Food and Drug Administration to authorize a third shoot of the Covid-19 vaccine for them with the agency’s spokeswoman saying they’re evaluating potential options, New York Post reports.

The authorization should come Thursday or Friday, though some speculate it might come later and it would only include two-dose Pfizer and Moderna jabs, but not the J&J one shot vaccine.

The Centers for Disease Control and Prevention will offer medical guidance after the authorization is issued and they will have meeting on Friday to decide if they’ll officially recommend booster shot for people that may not have as strong an immune response to the jabs and are 485 times more likely to die or be hospitalized, according to Johns Hopkins research data.

The CDC advisory group’s signoff is necessary before doctors can start prescribing extra doses

On top of that, FDA is expected to also grant full approval of the Pfizer vaccine since the all three jabs are still under an emergency order, preventing authorities from mandating vaccination in certain areas of the society.

Be the first to comment

Leave a Reply

Your email address will not be published.